Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy
Andrew D. Wells, … , Jeffrey A. Bluestone, Laurence A. Turka
Andrew D. Wells, … , Jeffrey A. Bluestone, Laurence A. Turka
Published September 15, 2001
Citation Information: J Clin Invest. 2001;108(6):895-904. https://doi.org/10.1172/JCI13220.
View: Text | PDF
Article Article has an altmetric score of 7

Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy

  • Text
  • PDF
Abstract

Primary T cell proliferative responses to TCR ligation plus CD28 costimulation are surprisingly heterogeneous. Many cells that enter G1 fail to progress further through the cell cycle, and some of these cells subsequently fail to divide upon restimulation, even in the presence of IL-2. Such IL-2–refractory anergy is distinct from the IL-2–reversible anergy induced by TCR occupancy in the absence of CD28 costimulation. Here, we focus on the contributions of cell cycle progression and costimulatory (CD28/CTLA-4) signals in the regulation of anergy. We show that CD28 costimulation is not sufficient for anergy avoidance and that activated T cells must progress through the cell cycle in order to escape anergy. Induction of this “division-arrest” form of anergy requires CTLA-4 signaling during the primary response. Also, cell division per se is not sufficient for anergy avoidance: the few T cells that undergo multiple rounds of cell division during overt CD28 costimulatory blockade do not escape the ultimate induction of clonal anergy. Anergy avoidance by primary T cells is thus a multistep process: in order to participate in a productive immune response, an individual T cell activated through its antigen receptor must receive CD28 costimulation and progress through the cell cycle. Anergy may be induced either through a combination of CTLA-4 signaling and the failure of cell cycle progression, or through a proliferation-independent mechanism in which TCR ligation occurs in the absence of CD28.

Authors

Andrew D. Wells, Matthew C. Walsh, Jeffrey A. Bluestone, Laurence A. Turka

×

Total citations by year

Year: 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Total
Citations: 1 3 2 3 1 3 3 3 1 2 2 1 3 3 4 4 1 1 1 2 44
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (44)

Title and authors Publication Year
RORγt+Foxp3+ regulatory T cells in the regulation of autoimmune arthritis.
Furuyama K, Kondo Y, Shimizu M, Yokosawa M, Segawa S, Iizuka A, Tanimura R, Tsuboi H, Matsumoto I, Sumida T
Clinical & Experimental Immunology 2022
Conversion of Anergic T Cells Into Foxp3- IL-10+ Regulatory T Cells by a Second Antigen Stimulus In Vivo
AS Thomann, T Schneider, L Cyran, IN Eckert, A Kerstan, MB Lutz
Frontiers in immunology 2021
The Integrative Analysis Identifies Three Cancer Subtypes and Stemness Features in Cutaneous Melanoma
X Wang, Q Wan, L Jin, C Liu, C Liu, Y Cheng, Z Wang
Frontiers in Molecular Biosciences 2021
Continuous Modeling of T CD4 Lymphocyte Activation and Function
D Martínez-Méndez, L Mendoza, C Villarreal, L Huerta
Frontiers in immunology 2021
Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints
KM Hargadon
Clinical and Translational Medicine 2020
Functional crosstalk between T cells and monocytes in cancer and atherosclerosis
LE Padgett, DJ Araujo, CC Hedrick, CE Olingy
Journal of leukocyte biology 2020
Bovine κ-Casein Fragment Induces Hypo-Responsive M2-Like Macrophage Phenotype
R Lalor, S ONeill
Nutrients 2019
Engineered Dendritic Cell-Directed Concurrent Activation of Multiple T cell Inhibitory Pathways Induces Robust Immune Tolerance
RR Gudi, S Karumuthil-Melethil, N Perez, G Li, C Vasu
Scientific Reports 2019
BTLA Expression on Th1, Th2 and Th17 Effector T-Cells of Patients with Systemic Lupus Erythematosus Is Associated with Active Disease
C Oster, B Wilde, C Specker, M Sun, A Kribben, O Witzke, S Dolff
International journal of molecular sciences 2019
Distribution of Cytotoxic T Lymphocyte-Associated Antigen-4 Promoter Polymorphisms in Taiwanese Patients with Type 2 Diabetes Mellitus
YL Shih, HF Lu, CW Hsiao, KT Ho, PC Chen, CN Huang, Y Chang, SJ Kao, MY Shiau, YH Chang
International journal of medical sciences 2018
Impact of Metabolism in on T-Cell Differentiation and Function and Cross Talk with Tumor Microenvironment
S Kouidhi, AB Elgaaied, S Chouaib
Frontiers in immunology 2017
ATVB Distinguished Scientist Award: How Costimulatory and Coinhibitory Pathways Shape Atherosclerosis
K Ley, N Gerdes, H Winkels
Arteriosclerosis, thrombosis, and vascular biology 2017
Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis
M Kishore, KC Cheung, H Fu, F Bonacina, G Wang, D Coe, EJ Ward, A Colamatteo, M Jangani, A Baragetti, G Matarese, DM Smith, R Haas, C Mauro, DC Wraith, K Okkenhaug, AL Catapano, VD Rosa, GD Norata, FM Marelli-Berg
Immunity 2017
Induction of CD4 + Regulatory and Polarized Effector/helper T Cells by Dendritic Cells
MB Lutz
Immune Network 2016
Low-Intensity Focused Ultrasound Induces Reversal of Tumor-Induced T Cell Tolerance and Prevents Immune Escape
S Bandyopadhyay, TJ Quinn, L Scandiuzzi, I Basu, A Partanen, WA Tome, F Macian, C Guha
Journal of immunology (Baltimore, Md. : 1950) 2016
Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches
R Diehl, F Ferrara, C Müller, AY Dreyer, DD McLeod, S Fricke, J Boltze
Cellular and Molecular Immunology 2016
Functional Characterization of Human T Cell Hyporesponsiveness Induced by CTLA4-Ig
Y Rochman, M Yukawa, AV Kartashov, A Barski, SJ Turner
PloS one 2015
CTLA-4 and MDR1 polymorphisms increase the risk for ulcerative colitis: A meta-analysis
JJ Zhao
World journal of gastroenterology : WJG 2015
Ndrg1 is a T-cell clonal anergy factor negatively regulated by CD28 costimulation and interleukin-2
YM Oh, HB Park, JH Shin, JE Lee, HY Park, DH Kho, JS Lee, H Choi, T Okuda, K Kokame, T Miyata, IH Kim, SH Lee, RH Schwartz, K Choi
Nature Communications 2015
The role of CTLA-4 exon-1 49 A/G polymorphism and soluble CTLA-4 protein level in egyptian patients with Behçet's disease
SM Galil, HA Hagrass
BioMed Research International 2014
Induction and stability of the anergic phenotype in T cells
R Valdor, F Macian
Seminars in Immunology 2013
Tle4 regulates epigenetic silencing of gamma interferon expression during effector T helper cell tolerance
S Bandyopadhyay, R Valdor, F Macian
Molecular and cellular biology 2013
Tumor suppressor TSC1 is critical for T-cell anergy
DL Xie, J Wu, YL Lou, XP Zhong
Proceedings of the National Academy of Sciences 2012
Cell-extrinsic effects of tumor ER stress imprint myeloid dendritic cells and impair CD8⁺ T cell priming
NR Mahadevan, V Anufreichik, JJ Rodvold, KT Chiu, H Sepulveda, M Zanetti
PloS one 2012
Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family
H Bour-Jordan, JH Esensten, M Martinez-Llordella, C Penaranda, M Stumpf, JA Bluestone
Immunological Reviews 2011
Allergen-specific subcutaneous immunotherapy in allergic asthma: immunologic mechanisms and improvement
YA Taher, PA Henricks, AJ van Oosterhout
The Libyan journal of medicine 2010
Receptor signaling in immune cell development and function
XP Zhong, J Shin, BK Gorentla, T O’Brien, S Srivatsan, L Xu, Y Chen, D Xie, H Pan
Immunologic Research 2010
Association of Single Nucleotide Polymorphisms in Cytotoxic T-Lymphocyte Antigen 4 and Susceptibility to Autoimmune Type 1 Diabetes in Tunisians
J Benmansour, M Stayoussef, FA Al-Jenaidi, MH Rajab, CB Rayana, HB Said, T Mahjoub, WY Almawi
Clinical and vaccine immunology : CVI 2010
CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance
J Kurtz, F Raval, C Vallot, J Der, M Sykes
Blood 2009
Immature and maturation-resistant human dendritic cells generated from bone marrow require two stimulations to induce T cell anergy in vitro
TG Berger, H Schulze-Koops, M Schäfer, E Müller, MB Lutz
PloS one 2009
The biology of interleukin-2 efficacy in the treatment of patients with renal cell carcinoma
AR de Chavez, ME de Vera, X Liang, MT Lotze
Medical Oncology 2009
Mechanism of cellular rejection in transplantation
E Ingulli
Pediatric nephrology (Berlin, Germany) 2008
Manipulating the immune system for anti-tumor responses and transplant tolerance via mixed hematopoietic chimerism
C Gibbons, M Sykes
Immunological Reviews 2008
Diacylglycerol kinases in immune cell function and self-tolerance
XP Zhong, R Guo, H Zhou, C Liu, CK Wan
Immunological Reviews 2008
Alloreactive CD8 T cell tolerance requires recipient B cells, dendritic cells and MHC class II
Fehr T, Haspot F, Mollov J, Chittenden M, Hogan T, Sykes M
Journal of immunology (Baltimore, Md. : 1950) 2008
IDO-expressing regulatory dendritic cells in cancer and chronic infection
A Popov, JL Schultze
Journal of Molecular Medicine 2007
Cyclin-dependent kinases: molecular switches controlling anergy and potential therapeutic targets for tolerance
AD Wells
Seminars in Immunology 2007
Molecular mechanisms for adaptive tolerance and other T cell anergy models
S Choi, RH Schwartz
Seminars in Immunology 2007
Therapeutic use of Aldara™ in chronic myeloid leukemia
AM Marleau, JH Lipton, NH Riordan, TE Ichim
Journal of Translational Medicine 2007
Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis
Veronica De Rosa, Claudio Procaccini, Antonio La Cava, Paolo Chieffi, Giovanni Francesco Nicoletti, Silvia Fontana, Serafino Zappacosta, and Giuseppe Matarese
Journal of Clinical Investigation 2006
Mesenchymal stem cells avoid allogeneic rejection
JM Ryan, FP Barry, JM Murphy, BP Mahon
Journal of Inflammation 2005
Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells.
Bensinger SJ, Walsh PT, Zhang J, Carroll M, Parsons R, Rathmell JC, Thompson CB, Burchill MA, Farrar MA, Turka LA
Journal of immunology (Baltimore, Md. : 1950) 2004
CD28 costimulation is required for in vivo induction of peripheral tolerance in CD8 T cells
MS Vacchio, RJ Hodes
Journal of Experimental Medicine 2003
T-Cell Anergy: From Phenotype to Genotype and Back
CM Seroogy, CG Fathman
Immunologic Research 2003

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 4 patents
Highlighted by 1 platforms
86 readers on Mendeley
See more details